fda compounding glp 1 Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA and Novo Nordisk Warn

some are single-use (e.g., dulaglutide, Wegovy) while others are multi-dose (e.g., Ozempic, Victoza/Saxenda)

Individuals with severe obesity, a long history of failed dieting, or metabolic conditions often see the strongest case for continued therapy

A 1/4 cup of kimchi , which is a fermented food that provides live, active cultures to help improve the composition of our gut microbiome

Trulicity is a once-weekly injection that comes as a single-use pre-filled pen

Stephanie Weiss, M.D., Ph.D., assistant director for the Clinical Research, Medication Development Program at NIDA, shared data from the first published clinical trial of GLP-1 RAs in alcohol use disorder: in patients with obesity with a BMI over 30, exenatide reduced heavy drinking days by 23.6% and lowered total alcohol intake